testing-phototherapy — source conflicts (round 11)

Conflict: [Dayal et al., An Bras Dermatol 2017] says 90% of children with moderate–severe AD cleared on NB-UVB. [Pavlovsky et al., JEADV 2011] says only 25% of children with AD cleared (Jury et al., CED 2006: 68%). Unresolved — add to open_questions.

Conflict: [Pharmaceutical Journal 2021 / Hourihane BMJ 1997] says refined arachis oil carries low allergic risk to the already-allergic. [Lack, NEJM 2003] links peanut-oil skin preparations with new peanut sensitisation (OR 6.8), without distinguishing refined oil. Unresolved — add to open_questions.